ClinicalTrials HQ

A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).

A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).

Recruiting · NCT04319367 · Registry updated 2024-04-17
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).AIDS, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted diseaseRecruitingPhase 22024-04-17NCT04319367

4 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Bill and Melinda Gates Foundation67
Imperial College London220
Rockefeller University21
University of Oxford213

12 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Aarhus University HospitalAarhusDenmark77
Barts Health NHS TrustLondonUnited Kingdom30
Chelsea and Westminster Hospital NHS Foundation TrustLondonUnited Kingdom3
Guy's and St Thomas' NHS Foundation TrustLondonUnited Kingdom26
Imperial College NHS Healthcare TrustLondonUnited Kingdom1
Manchester University NHS Foundation TrustManchesterUnited Kingdom17
Mortimer Market CNWL Hospital NHS Foundation TrustLondonUnited Kingdom1
Oxford University HospitalsOxfordUnited Kingdom10
Royal Free London NHS Foundation TrustLondonUnited Kingdom15
St Georges Hospital NHS Foundation TrustLondonUnited Kingdom1
University Hospitals Sussex NHS Foundation TrustBrightonUnited Kingdom5
Western General HospitalEdinburghUnited Kingdom23